Frederick Baehner MD

Rick Baehner, M.D., is the Chief Medical Officer of Precision Oncology at Exact Sciences which is focused on improving the quality of treatment decisions for cancer patients. He and his colleagues have worked together with leading global oncology clinical research groups to use new molecular diagnostic methods and rigorous clinical studies to develop and commercialize the Oncotype DX® breast cancer, colon cancer, prostate cancer, and liquid biopsy assays. Dr. Baehner is also an associate professor at the University of California, San Francisco.